12P Circulating tumor DNA as early marker of response to treatment in stage IV gastrointestinal cancerdoi:10.1016/j.annonc.2022.01.014P. KirchwegerA. KupferthalerJ. BurghoferG. WebersinkeE. JukicS. SchwendingerR. FüggerM. BieblH. Wundsam...
Treatment of Patients with Stage IV Gastric Cancer Purpose Treatment of patients with stage IV gastric cancer is controversial. This study was retrospectively designed to elucidate the best treatment for th... M Ikeguchi,A Kader,S Takaya,... - 《Journal of Gastrointestinal Cancer》 被引量: 6发...
- 《Journal of Gastrointestinal Cancer》 被引量: 6发表: 2013年 Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer The five patients who survived more than 5 years after hepatic resection had a D2 lymphadenectomy, modest lymphatic invasion, primary gastric ...
Dr. Berri: If you’ve been told you have a tumor of the GI [gastrointestinal] tract or of the abdominal cavity and it has spread, at the least you should inquire about this possible treatment. If felt appropriate by the surgeon or the doctors taking care of you, then you really should...
2009;11(4):287-292. PubMedGoogle ScholarCrossref 3. Feuer DJ, Broadley KE, Shepherd JH, Barton DP; Systematic Review Steering Committee. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. Gynecol Oncol. 1999;75(3):313-322.PubMed...
To improve oral intake for gastric outlet obstruction in GC, gastrointestinal stent placement is also a candidate, along with distal gastrectomy and gastrojejunostomy. There is no consensus on the overall survival in gastrointestinal stent placement and gastrojejunostomy [15,16]. Keranen et al. reported...
Stage 4 mesothelioma is the most advanced stage of the cancer. Learn about symptoms, survival rate, prognosis and treatment options here.
While many other types of cancer including lung, renal and melanoma have responded dramatically to immune therapies, several gastrointestinal cancers have been resistant, potentially decreasing interest in continued testing of immunotherapies in this population. ...
infusion for 4 days) was given in 21-day cycles. The following eligibility criteria were used for patients’ enrollment: age <75 years; free from distant metastatic disease; stages IIIA, IIIB, and IV (only non-metastatic cases, T4 N1-3 and T1-3 N3; AJCC Cancer Staging, 6th edition);...
A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Commun (Lond). 2021;41(11):1137-1151. doi:10.1002/cac2.12220PubMedGoogle ScholarCrossref 8. Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, et al. Metabolic ...